Matches in Nanopublications for { ?s ?p "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP967627.RAQ9A1WIdzTyjamGI3dplEGHbjHW2BgZMFs0nFvWTVaes130_assertion description "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967627.RAQ9A1WIdzTyjamGI3dplEGHbjHW2BgZMFs0nFvWTVaes130_provenance.
- NP967631.RAUZS_Os89w3-tOmttNTHl-JRRq01B5vKGg3u8K_5cT_c130_assertion description "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967631.RAUZS_Os89w3-tOmttNTHl-JRRq01B5vKGg3u8K_5cT_c130_provenance.
- NP967638.RAdTs5uXSoNLmA7Qj2N3XzLXrW8RT7FBfA_CRG1N4CSRI130_assertion description "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967638.RAdTs5uXSoNLmA7Qj2N3XzLXrW8RT7FBfA_CRG1N4CSRI130_provenance.
- NP967629.RAl2ddtb7W85jqN2UgV6HHFQhtxFPzV-131id4rErO8Ko130_assertion description "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967629.RAl2ddtb7W85jqN2UgV6HHFQhtxFPzV-131id4rErO8Ko130_provenance.
- NP967632.RAkktdc6HwxZ_CRYsf4kauj-9UN3i9MSKkMWBOx7VkrVo130_assertion description "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967632.RAkktdc6HwxZ_CRYsf4kauj-9UN3i9MSKkMWBOx7VkrVo130_provenance.
- NP967633.RANiLwuXQVgmKYwoPJy06fnF2BfoTRO8B5YDhdMuo5qRs130_assertion description "[Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967633.RANiLwuXQVgmKYwoPJy06fnF2BfoTRO8B5YDhdMuo5qRs130_provenance.